Skip to main content

Table 30 (abstract A565). Data shown as median (IQR); ^p<0.05 versus placebo

From: ESICM LIVES 2016: part two

  

Control (n=6)

Predicted survival (n=7)

Predicted non-survival (n=5)

IL-6 (ng/mL)

Placebo

0.1 (0.0–0.1)

2.1 (2.0–3.5)

12.9 (8.2–18.4)

Esmolol

-

1.4 (1.0–1.7) ^

3.0 (2.2–4.5) ^

IL-10 (ng/mL)

Placebo

0.0 (0.0–0.1)

0.4 (0.2–0.6)

0.7 (0.4–1.0)

Esmolol

-

1.4 (1.3–3.2) ^

1.2 (0.7–3.2)

Adrenaline (ng/mL)

Placebo

5.5 (4.7–6.3)

7.1 (5.3–15.4)

6.2 (5.5–12.8)

Esmolol

-

6.4 (5.2–12.3)

8.9 (7.0–9.3)

Noradrenaline (ng/mL)

Placebo

0.5 (0.2–0.7)

3.2 (2.9–4.8)

3.2 (1.2–5.1)

Esmolol

-

2.6 (2.0–3.5)

3.0 (1.4–5.0)